Claudin18.2 重组兔单克隆抗体
Specifications
- 产品注册名称
- 细胞紧密连接蛋白18.2（Claudin18.2）抗体试剂（免疫组织化学法）
- 目录号
- I1241
- 克隆号
- BP6249
- 亚细胞定位
- 细胞膜
- 阳性对照
- 胃
- 修复方式
- HIER
- 组织类型
- FFPE
- 规格
- 浓缩液：0.1mL/1mL 工作液：1.5mL/7mL
- 用途
- NMPA IVD
Applicable platform
- Biolynx平台
- Leica平台
- Roche平台
- Dako平台
Reference
1. Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer. [J] . Baek Jin Ho,Park Dong Jin,Kim Gyu Yeol,Cheon Jaekyung,Kang Byung Woog,Cha Hee Jeong,Kim Jong Gwang. Anticancer research . 2019 (12)
2. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study. [J] . Dottermusch Matthias,Krüger Sandra,Behrens
Hans-Michael,Halske Christine,R?cken Christoph. Virchows Archiv : an international journal of pathology . 2019 (5).
3. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma. [J] . Rohde Christoph,Yamaguchi Rin,Mukhina Svetlana,Sahin Ugur,Itoh Kyogo,Türeci ?zlem. Japanese journal of clinical oncology . 2019 (9).
